These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 12874014)

  • 21. HLA-G promotes immune tolerance.
    Rouas-Freiss N; Paul P; Dausset J; Carosella ED
    J Biol Regul Homeost Agents; 2000; 14(2):93-8. PubMed ID: 10841284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.
    Sáenz-López P; Gouttefangeas C; Hennenlotter J; Concha A; Maleno I; Ruiz-Cabello F; Cózar JM; Tallada M; Stenzl A; Rammensee HG; Garrido F; Cabrera T
    Tissue Antigens; 2010 Feb; 75(2):110-8. PubMed ID: 19912575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment.
    Schendel DJ; Gansbacher B
    Cancer Res; 1993 Sep; 53(17):4020-5. PubMed ID: 8358731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: methodological implications for immunotherapy.
    Hanak L; Slaby O; Lauerova L; Kren L; Nenutil R; Michalek J
    Med Sci Monit; 2009 Dec; 15(12):CR638-43. PubMed ID: 19946235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
    Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
    Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.
    Gaudin C; Kremer F; Angevin E; Scott V; Triebel F
    J Immunol; 1999 Feb; 162(3):1730-8. PubMed ID: 9973436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction.
    Biswas K; Richmond A; Rayman P; Biswas S; Thornton M; Sa G; Das T; Zhang R; Chahlavi A; Tannenbaum CS; Novick A; Bukowski R; Finke JH
    Cancer Res; 2006 Jul; 66(13):6816-25. PubMed ID: 16818659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes.
    Seliger B; Rongcun Y; Atkins D; Hammers S; Huber C; Störkel S; Kiessling R
    Int J Cancer; 2000 Aug; 87(3):349-59. PubMed ID: 10897039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
    Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.
    Jantzer P; Schendel DJ
    Cancer Res; 1998 Jul; 58(14):3078-86. PubMed ID: 9679974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tumour suppressor gene CEACAM1 is completely but reversibly downregulated in renal cell carcinoma.
    Kammerer R; Riesenberg R; Weiler C; Lohrmann J; Schleypen J; Zimmermann W
    J Pathol; 2004 Nov; 204(3):258-67. PubMed ID: 15476270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA class I and II antigens expression in patients with renal cell carcinoma.
    Ozgur BC; Gonenc F; Yazicioglu AH
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):97-101. PubMed ID: 19112225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma.
    Ibrahim EC; Allory Y; Commo F; Gattegno B; Callard P; Paul P
    Am J Pathol; 2003 Feb; 162(2):501-8. PubMed ID: 12547708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-G expression in malignant melanoma.
    Rebmann V; Wagner S; Grosse-Wilde H
    Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
    Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of MHC antigen expression and tumor-infiltrating mononuclear cells in renal cell adenomas and carcinomas.
    Ohmori T; Okada K; Arita N; Watanabe Y; Miyazaki T; Tabei R
    Histol Histopathol; 1995 Oct; 10(4):789-94. PubMed ID: 8573998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
    Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
    J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-G expression: immune privilege for tumour cells?
    Cabestre FA; Lefebvre S; Moreau P; Rouas-Friess N; Dausset J; Carosella ED; Paul P
    Semin Cancer Biol; 1999 Feb; 9(1):27-36. PubMed ID: 10092548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptidome from renal cell carcinoma contains antigens recognized by CD4+ T cells and shared among tumors of different histology.
    Tassi E; Facchinetti V; Seresini S; Borri A; Dell'antonio G; Garavaglia C; Casorati G; Protti MP
    Clin Cancer Res; 2006 Aug; 12(16):4949-57. PubMed ID: 16914584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.